IsoRay to sell $2.25 million in common stock

[News]

IsoRay Inc. has entered a securities purchase agreement with an investor to sell $2.25 million in common stock with the potential of $2,075,000 additional funding through two subsequent short term warrant tranches of 90 days and 180 days assuming an average exercise price of $1.40 and that all Series A and B warrants are exercised. Additional funding will occur if Series C or D warrants are exercised.

More... (http://www.news-medical.net/news/20101122/IsoRay-to-sell-24225-million-in-common-stock.aspx)